Literature DB >> 35345741

Haemophilus parainfluenzae Pyogenic Liver Abscess Associated With Cholangiocarcinoma.

Mathew C Finniss1, Lamis Ibrahim1.   

Abstract

Haemophilus parainfluenzae (H. parainfluenzae) is a commensal organism of the gastrointestinal tract. It rarely causes hepatobiliary infections; however, in the presence of underlying inflammation, immunosuppression, or malignancy, it can cause hepatobiliary infection via an ascending route. Herein, we report a case of pyogenic liver abscess secondary to H. parainfluenzae associated with cholangiocarcinoma, which was treated with ceftriaxone and metronidazole.
Copyright © 2022, Finniss et al.

Entities:  

Keywords:  cholangiocarcinoma; haemophilus parainfluenzae; hepatobiliary infection; liver abscess; pyogenic

Year:  2022        PMID: 35345741      PMCID: PMC8956487          DOI: 10.7759/cureus.22501

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  5 in total

1.  Haemophilus parainfluenzae liver abscess after successful liver transplantation.

Authors:  J Friedl; A Stift; G A Berlakovich; S Taucher; M Gnant; R Steininger; F Mühlbacher
Journal:  J Clin Microbiol       Date:  1998-03       Impact factor: 5.948

2.  Haemophilus parainfluenzae biliary tract infection: rationale for an ascending route of infection from the gastrointestinal tract.

Authors:  E J Bottone; D Y Zhang
Journal:  J Clin Microbiol       Date:  1995-11       Impact factor: 5.948

3.  Haemophilus parainfluenzae biliary tract infections.

Authors:  D Pierard; B De Waele; L Covens; A Van Zeebroeck; P Rosseel; S Lauwers
Journal:  J Clin Microbiol       Date:  1996-07       Impact factor: 5.948

Review 4.  Hepatobiliary infections caused by Haemophilus species.

Authors:  T A O'Bryan; C J Whitener; M Katzman; P C Appelbaum
Journal:  Clin Infect Dis       Date:  1992-10       Impact factor: 9.079

5.  Liver abscess caused by Haemophilus parainfluenzae.

Authors:  B Chattopadhyay; P H Silverstone; R S Winwood
Journal:  Postgrad Med J       Date:  1983-12       Impact factor: 2.401

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.